The present invention relates to pharmaceutical compositions comprising a
FRMD3 polynucleotide or polypeptide as well as diagnostic compositions,
devices or kits comprising a FRMD3 polynucleotide or polypeptide as well
as antibodies or oligonucleotides derived therefrom. Moreover, the
present invention relates to methods and uses for diagnosing or treating
a hyperproliferative disorder based on the aforementioned FRMD3
polynucleotides or polypeptides.